**Author details**

Blaženka Kljaić Bukvić 1,2,3\*, Mario Blekić 1,2,3 and Marija Pečnjak1

1 Pediatric Department, General Hospital "Dr. Josip Benčević", Croatia

2 School of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia

3 Faculty of Dental Medicine and Health Care, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia

\*Address all correspondence to: blazenka.bukvic@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**11**

*Allergic March*

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.85553*

[9] Paternoster L et al. Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts. The Journal of Allergy and Clinical Immunology. 2018;**141**(3):964-971

[10] Barker JN et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. The Journal of Investigative Dermatology. 2007;**127**(3):564-567.

[11] Margolis DJ et al. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis. JAMA Dermatology. 2014;**150**(3):254-259. DOI: 10.1001/

[12] Ashley SE et al. The skin barrier function gene SPINK5 is associated with challenge-proven IgE-mediated food allergy in infants. Allergy. 2017;**72**(9):1356-1364. DOI: 10.1111/

[13] Marenholz I, Esparza-Gordillo J, Lee YA. The genetics of the skin barrier in eczema and other allergic disorders. Current Opinion in Allergy and Clinical Immunology. 2015;**15**(5):426-434. DOI: 10.1097/aci.0000000000000194

[14] Cianferoni A, Spergel J. The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Review of Clinical Immunology. 2014;**10**(11):1463-1474. DOI: 10.1586/1744666x.2014.967684

[15] Czarnowicki T, Krueger JG, Guttman-Yassky E. Skin barrier and immune dysregulation in atopic dermatitis: An evolving story with important clinical implications. The Journal of Allergy and Clinical Immunology. In Practice. 2014;**2**(4): 371-379. Quiz 380-1. DOI: 10.1016/j.

jaip.2014.03.006

DOI: 10.1038/sj.jid.5700587

jamadermatol.2013.7954

all.13143

[1] Boyce JA et al. Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-sponsored expert panel report. The Journal of Allergy and Clinical Immunology.

[2] Nwaru BI et al. Prevalence of common food allergies in Europe: A systematic review and meta-analysis.

Allergy. 2014;**69**(8):992-1007

[3] Prescott S, Allen KJ. Food allergy: Riding the second wave of the allergy epidemic. Pediatric Allergy and Immunology. 2011;**22**(2):155-160

[4] van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: A systematic review. The Journal of Allergy and Clinical Immunology.

[5] Thomsen SF. Epidemiology and natural history of atopic diseases. European Clinical Respiratory Journal. 2015;**2**. DOI: 10.3402/ecrj.v2.24642

[6] Belgrave DC et al. Atopic dermatitis and respiratory allergy: What is the link. Current Dermatology Reports. 2015;**4**(4):221-227. DOI: 10.1007/

[7] Goksor E et al. The allergic march comprises the coexistence of related patterns of allergic disease not just the progressive development of one disease. Acta Paediatrica. 2016;**105**(12):1472-

1479. DOI: 10.1111/apa.13515

2013;**93**(4):438-441. DOI: 10.2340/00015555-1522

[8] Bingefors K et al. Self-reported lifetime prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood: A population-based cross-sectional survey. Acta Dermato-Venereologica.

2010;**126**(6):1105-1118

2007;**120**(3):565-569

s13671-015-0121-6

### *Allergic March DOI: http://dx.doi.org/10.5772/intechopen.85553*
